Open Access

Erratum to: n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis

  • Lorenzo Pradelli1Email author,
  • Konstantin Mayer2,
  • Maurizio Muscaritoli3 and
  • Axel R Heller4
Critical Care201317:405

https://doi.org/10.1186/cc11909

Published: 7 January 2013

The original article was published in Critical Care 2012 16:R184

Correction

Following publication of their article [1], the authors noticed that Table 2 should list medium chain triglycerides (MCT) instead of olive oil emulsion (OO) in the column 'Standard lipid emulsion' as follows;
Table 2

Studies evaluating n-3 PUFA-enriched lipid emulsions for parenteral nutrition and reported outcomes/measured parameters

Study

Setting (n)

n-3 PUFA-enriched lipid emulsion

Standard lipid emulsion

Clinical outcomes

Laboratory outcomes

ICU patients a ( n = 762)

     

Antebi 2004 [6]

Major surgery (20)

SO/MCT/OO/FOb

SO

 

ASTc, ALTc, CRP, alpha-T, TGc

Barbosa 2010 [7]

Sepsis (23)

SO/MCT/n-3 TGsd

SO/MCT

H LOS, ICU LOS, Mortality

CRP, EPA, DHA, AA, LTB4, AST, ALT, Bilirubin, OI, IL-6, PTT, Lac

Berger 2008 [8]

Abdominal aortic aneurysm (24)

SO/MCT/n-3 TGsd

SO/MCT

Mortality, H LOS, ICU LOS

EPA, DHA, AA, alpha-T, CRP, TG

Friesecke 2008 [9]

Critical medical (165)

SO + FOe

SO/MCT

Mortality, Infection rate, ICU LOS, Bleeding events

IL-6f TBU

Heller 2004 [10]

Elective colorectal (44)

SO + FOe

SO

ICU LOS

AST, ALT, CRP, Bilirubin, PT (Quick), PTT, TBU

Morlion 1996 [11]

Gastric carcinoma (20)

SO + FOe

SO

 

AA, EPA, DHA, LTB5, LTB4

Piper 2009 [12]

Major abdominal or craniomaxillofacial surgery (44)

SO/MCT/OO/FOb

SO/OO

 

AST, ALT, TG

Roulet 1997 [13]

Elective oesophagectomy (19)

SO + FOe

SO

 

EPA, DHA, AA, BT

Sabater 2011 [14]

Acute respiratory distress syndrome (44)

SO/MCT/n-3 TGsd

SO

Mortality

LTB4

Wachtler 1997 [15]

Elective abdominal surgery (40)

SO/MCT/n-3 TGsd

SO/MCT

Infection rate, H LOS, ICU LOS

LTB4, LTB5, LTB ratio, IL-6f

Wang 2008 [16]

Severe acute pancreatitis (40)

SO + FOe

SO

Mortality, Infection rate, H LOS, ICU LOS

EPA, CRP, OI

Weiss 2002 [17]

Gastrointestinal surgery (23)

SO + FOe

SO

Mortality, Infection rate, H LOS, ICU LOS

IL-6g

Wichmann 2007 [18]

Major intestinal surgery (256)

SO/MCT/n-3 TGsd

SO

Mortality, Infection rate, H LOS, ICU LOS

AST, Bilirubin, TG, CRP, LTB5, LTB ratio, alpha-T, EPA, PT (Quick), Cr

Elective surgery, non-ICU patients ( n = 740)

   

Badia-Tahull 2010 [19]

Major gastrointestinal surgery (27)

SO + FOe

SO/OO

Mortality, H LOS, Infection rate

ALT, CRP, TBU, Cr, PlU

Grimm 2006 [20]

Radical colorectal cancer resection (33)

SO/MCT/OO/FOb

SO

H LOSc

alpha-T, AA, EPA, DHA, LTB4, LTB5, LTB ratio

Jiang 2010 [21]

Gastrointestinal malignancy (203)

SO + FOe

SO

H LOS, Infection rate, Bleeding events

IL-6, CrCl

Klek 2005 [22]

Major abdominal surgery (58)

SO + FOe

SO/MCT

H LOS, Infection rate

ALT, AST, Cr, PlU

Koeller 2003 [23]

Major abdominal surgery (30)

SO/MCT/n-3 TGsd

SO

 

LTB4, LTB5, LTB ratio

Liang 2008 [24]

Colorectal cancer (41)

SO + FOe

SO

Mortality, Infection rate, H LOS

IL-6

Linseisen 2000 [25]

Major abdominal surgery (33)

SO/MCT/n-3 TGscd

SO

 

alpha-T, AA, EPA, DHA

Makay 2011 [26]

Major gastric surgery (26)

SO + FOe

SO

Mortality, Infection rate, H LOS

AST, ALT, Cr, PlU; Lac

Mertes 2006 [27]

Abdominal surgery (249)

SO/MCT/OO/FOb

SO

Mortality, H LOS

AST, ALT, TG, Bilirubin

Senkal 2007 [28]

Major abdominal cancer (40)

SO/MCT/n-3 TGsd

SO/MCT

Infection rate

AA, EPA, DHA

aAllocation to the ICU subgroup was driven by explicit mention in the published paper of an ICU stay, in the Methods or Results sections of the original article. bSMOFlipid 20% (Fresenius Kabi): 1000 ml of emulsion contains: soya-bean oil, refined 60.0 g, triglycerides, medium-chain, 60.0 g, olive oil, refined 50.0 g, FO, rich in n-3-acids 30.0 g. cNot used for meta-analysis as data are from a subgroup of Mertes et al. [27]. dLipoplus 20% (B.Braun): 1000 ml of emulsion contains: medium-chain triglycerides: 100.0 g, soybean oil, refined: 80.0 g, N-3-acid triglycerides: 20.0 g. eOmegaven 10% fish oil emulsion (Fresenius Kabi): 100 ml emulsion contains highly refined fish oil 10.0 g containing eicosapentaenoic acid (EPA) 1.25 to 2.82 g, docosahexaenoic acid (DHA) 1.44 to 3.09 g, dl-α-tocopherol (as antioxidant) 0.015 to 0.0296 g. fData reported by graph only or qualitatively. gNo SD reported. AA, (%) content of arachidonic acid in serum/cellular membranes; alpha-T, alpha-tocopherol; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BT, bleeding time; Cr, serum creatinine; CrCl, creatinine clearance; CRP, C-reactive protein; DHA,(%) docosahexaenoic acid content in serum/cellular membranes; EPA, (%) eicosapentaenoic acid content in serum/cellular membranes; FO, fish oil emulsion; Lac, lactate; (H) LOS, (Hospital) length of stay; ICU, intensive care unit; LTB, leukotriene B; LTB ratio, LTB5: LTB4; (n-3) TGs, (n-3) triglycerides; MCT, medium chain triglycerides; OI, oxygenation index; OO, olive oil emulsion; PlU, serum urea; PT, prothrombin time; PTT, partial thromboplastin time; SO, soybean oil emulsion; TBU, transfused blood units.

  • For the study Barbosa 2010 [7], this column should read SO/MCT

  • For the study Berger 2008 [8], this column should read SO/MCT

  • For the study Friesecke 2008 [9], this column should read SO/MCT

  • For the study Wachtler 1997 [15], this column should read SO/MCT

  • For the study Klek 2005 [22], this column should read SO/MCT

  • For the study Senkal 2007 [28], this column should read SO/MCT

  • The correct version of the table appears overleaf.

Notes

Declarations

Authors’ Affiliations

(1)
AdRes HE&OR, Piazza Carlo Emanuele II 19, I-10123
(2)
Department of Internal Medicine, Lung Transplant Program, Internal Medicine, Pulmonary Medicine, Intensive Care Medicine, Sleep Medicine.Justus-Liebig University Giessen
(3)
Internal Medicine, Università La Sapienza,
(4)
Clinic for Anaesthesiology,Intensive Therapy, University Dresden

References

  1. Pradelli L, Mayer K, Muscaritoli M, Heller AR: n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care 2012, 16: R184. 10.1186/cc11668PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2013

Advertisement